Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen in Oesophageal Cancer
NCT02513849Phase 1Unknown
- Sponsor
- University of Nottingham
- Start
- Dec 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tamoxifen in esophageal cancer, sponsored by University of Nottingham. Primary endpoint: Change in Ki67 expression at 4 weeks. Status: unknown.
02
Drugs
tamoxifen
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02513849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513849.